Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2011

01-12-2011 | Poster presentation

microRNA and protein expression in breast cancer formalin-fixed paraffin-embedded samples

Authors: A Gámez-Pozo, I Sánchez-Navarro, CA Castaneda, NI Ferrer, G de Velasco, FG Martínez, E Ciruelos, JÁ Fresno Vara

Published in: Breast Cancer Research | Special Issue 2/2011

Login to get access

Excerpt

microRNAs (miRNAs) constitute a new class of small noncoding RNAs that control post-transcriptionally the expression of gene products, either modulating directly protein translation or regulating the stability of messenger RNA. There is increasing evidence of the role that miRNAs play in regulating breast cancer gene expression. The main objective of this study is to evaluate the diagnostic utility of the expression of a panel of miRNAs in breast cancer and compare their expression with the expression of the proteins they regulate. …
Metadata
Title
microRNA and protein expression in breast cancer formalin-fixed paraffin-embedded samples
Authors
A Gámez-Pozo
I Sánchez-Navarro
CA Castaneda
NI Ferrer
G de Velasco
FG Martínez
E Ciruelos
JÁ Fresno Vara
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2011
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3031

Other articles of this Special Issue 2/2011

Breast Cancer Research 2/2011 Go to the issue

Poster presentation

Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy

Poster presentation

Clinical features and prognosis of tubular breast cancer

Poster presentation

The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer

Oral presentation

Translational breast cancer research in luminal breast cancer

Oral presentation

The phosphatidylinositol-3 kinase/mTOR pathway: new agents

Oral presentation

DNA repair and breast cancer: therapeutic opportunities
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits